{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T14:04:12Z","timestamp":1780409052379,"version":"3.54.1"},"reference-count":59,"publisher":"MDPI AG","issue":"11","license":[{"start":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T00:00:00Z","timestamp":1780358400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Prostate cancer (PCa) remains a major global health concern, with a subset of patients progressing to aggressive disease despite advances in diagnosis and treatment. Epithelial\u2013mesenchymal transition (EMT) plays a pivotal role in tumor invasion, metastasis, and immune evasion; however, its cellular heterogeneity and clinical relevance in PCa remain incompletely understood. We analyzed single-cell transcriptomic data to characterize EMT dynamics in malignant epithelial cells. Malignant cells were identified based on aberrant copy number variation patterns, and EMT activity was quantified using AUCell. Gene expression profiling and gene set enrichment analysis identified key EMT-associated genes. By integrating bulk transcriptomic data with LASSO regression analysis, we identified five pivotal genes and constructed an EMT infiltration scoring model. The model demonstrated robust predictive performance in an external Gene Expression Omnibus validation cohort and effectively predicted early biochemical recurrence. Further analyses revealed significant associations between EMT scores, clinicopathological features, immune cell infiltration, genomic instability, and tumor immune dysfunction and exclusion scores. Pathway enrichment analysis highlighted distinct molecular characteristics between high- and low-score groups. Additionally, molecular docking using AutoDock identified potential targeted therapeutic agents for key EMT genes. Overall, this study systematically delineates EMT heterogeneity at the single-cell level and establishes a robust EMT infiltration model for prognostic prediction and therapeutic guidance in PCa, providing novel insights for precision risk stratification and individualized treatment strategies.<\/jats:p>","DOI":"10.3390\/ijms27115017","type":"journal-article","created":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T12:45:08Z","timestamp":1780404308000},"page":"5017","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Integrated Single-Cell RNA-Seq and Machine Learning to Construct an EMT Infiltration Scoring Model for Prostate Cancer"],"prefix":"10.3390","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-8674-7629","authenticated-orcid":false,"given":"Zhipeng","family":"Xie","sequence":"first","affiliation":[{"name":"Tumor and Aging Laboratory, Kunming University of Science and Technology, Kunming 650500, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingjie","family":"Sun","sequence":"additional","affiliation":[{"name":"Tumor and Aging Laboratory, Kunming University of Science and Technology, Kunming 650500, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuheng","family":"Tang","sequence":"additional","affiliation":[{"name":"Tumor and Aging Laboratory, Kunming University of Science and Technology, Kunming 650500, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Qi","sequence":"additional","affiliation":[{"name":"Tumor and Aging Laboratory, Kunming University of Science and Technology, Kunming 650500, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaxiang","family":"Liang","sequence":"additional","affiliation":[{"name":"Tumor and Aging Laboratory, Kunming University of Science and Technology, Kunming 650500, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiehui","family":"Zhang","sequence":"additional","affiliation":[{"name":"Tumor and Aging Laboratory, Kunming University of Science and Technology, Kunming 650500, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0769-6448","authenticated-orcid":false,"given":"Wenru","family":"Tang","sequence":"additional","affiliation":[{"name":"Tumor and Aging Laboratory, Kunming University of Science and Technology, Kunming 650500, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuhong","family":"Zhou","sequence":"additional","affiliation":[{"name":"Office of Science and Technology, Yunnan University of Chinese Medicine, Kunming 650500, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,6,2]]},"reference":[{"key":"ref_1","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1590\/s1677-5538.ibju.2016.0656","article-title":"Biochemical recurrence after radical prostatectomy: What does it mean?","volume":"44","author":"Srougi","year":"2018","journal-title":"Int. Braz. J. Urol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1038\/s41580-020-0237-9","article-title":"Guidelines and definitions for research on epithelial-mesenchymal transition","volume":"21","author":"Yang","year":"2020","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.cell.2016.06.028","article-title":"EMT: 2016","volume":"166","author":"Nieto","year":"2016","journal-title":"Cell"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"eaam6826","DOI":"10.1126\/scisignal.aam6826","article-title":"Loss of SPDEF and gain of TGFBI activity after androgen deprivation therapy promote EMT and bone metastasis of prostate cancer","volume":"10","author":"Chen","year":"2017","journal-title":"Sci. Signal."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.tcb.2018.12.001","article-title":"EMT Transition States during Tumor Progression and Metastasis","volume":"29","author":"Pastushenko","year":"2019","journal-title":"Trends Cell Biol."},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Li, Y., Li, K., Wang, H., Qiu, J., and Xiao, C. (2025). Identification of epithelial-mesenchymal transition prognostic signature associated with prognosis, tumor microenvironment, and therapeutic effect in prostate cancer. Front. Genet., 16.","DOI":"10.3389\/fgene.2025.1539745"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1186\/s13046-021-01874-1","article-title":"Single-cell RNA sequencing in cancer research","volume":"40","author":"Zhang","year":"2021","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s12276-018-0071-8","article-title":"Single-cell RNA sequencing technologies and bioinformatics pipelines","volume":"50","author":"Hwang","year":"2018","journal-title":"Exp. Mol. Med."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1038\/s41587-020-00795-2","article-title":"Delineating copy number and clonal substructure in human tumors from single-cell transcriptomes","volume":"39","author":"Gao","year":"2021","journal-title":"Nat. Biotechnol."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Yao, J., Zhang, Y., Li, M., Sun, Z., Liu, T., Zhao, M., and Li, Z. (2022). Single-Cell RNA-Seq Reveals the Promoting Role of Ferroptosis Tendency During Lung Adenocarcinoma EMT Progression. Front. Cell Dev. Biol., 9.","DOI":"10.3389\/fcell.2021.822315"},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"H\u00e4nzelmann, S., Castelo, R., and Guinney, J. (2013). GSVA: Gene set variation analysis for microarray and RNA-seq data. BMC Bioinform., 14.","DOI":"10.1186\/1471-2105-14-7"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1038\/modpathol.2010.158","article-title":"International Society of Urological Pathology (ISUP) Consensus Conference on Handling and Staging of Radical Prostatectomy Specimens. Working group 3: Extraprostatic extension, lymphovascular invasion and locally advanced disease","volume":"24","author":"Evans","year":"2011","journal-title":"Mod. Pathol."},{"key":"ref_14","first-page":"1194","article-title":"Assessment of biochemical recurrence of prostate cancer","volume":"55","author":"Lin","year":"2019","journal-title":"Int. J. Oncol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.21037\/tcr.2019.09.54","article-title":"Infiltrating regulatory T cells promote invasiveness of liver cancer cells via inducing epithelial-mesenchymal transition","volume":"8","author":"Huang","year":"2019","journal-title":"Transl. Cancer Res."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/s41580-018-0080-4","article-title":"New insights into the mechanisms of epithelial-mesenchymal transition and implications for cancer","volume":"20","author":"Dongre","year":"2019","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1126\/science.aaa1348","article-title":"Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer","volume":"348","author":"Rizvi","year":"2015","journal-title":"Science"},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Semenov, O., Daks, A., Fedorova, O., Shuvalov, O., and Barlev, N.A. (2022). Opposing Roles of Wild-type and Mutant p53 in the Process of Epithelial to Mesenchymal Transition. Front. Mol. Biosci., 9.","DOI":"10.3389\/fmolb.2022.928399"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1038\/s41591-018-0136-1","article-title":"Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response","volume":"24","author":"Jiang","year":"2018","journal-title":"Nat. Med."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1146\/annurev-pathol-042020-042741","article-title":"Immune Checkpoint Inhibitors for the Treatment of Cancer: Clinical Impact and Mechanisms of Response and Resistance","volume":"16","author":"Bagchi","year":"2021","journal-title":"Annu. Rev. Pathol."},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Kciuk, M., Gieleci\u0144ska, A., Mujwar, S., Ko\u0142at, D., Ka\u0142uzi\u0144ska-Ko\u0142at, \u017b., Celik, I., and Kontek, R. (2023). Doxorubicin-An Agent with Multiple Mechanisms of Anticancer Activity. Cells, 12.","DOI":"10.3390\/cells12040659"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"377","DOI":"10.2165\/11318860-000000000-00000","article-title":"Sunitinib: A multitargeted receptor tyrosine kinase inhibitor in the era of molecular cancer therapies","volume":"23","author":"Papaetis","year":"2009","journal-title":"BioDrugs"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1093\/annonc\/mdl347","article-title":"Antiemetic activity of corticosteroids in patients receiving cancer chemotherapy: Dosing, efficacy, and tolerability analysis","volume":"18","author":"Grunberg","year":"2007","journal-title":"Ann. Oncol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.2174\/156802606777812068","article-title":"Hsp90: A novel target for cancer therapy","volume":"6","author":"Solit","year":"2006","journal-title":"Curr. Top. Med. Chem."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"5541","DOI":"10.1038\/sj.onc.1210620","article-title":"Histone deacetylase inhibitors: Molecular mechanisms of action","volume":"26","author":"Xu","year":"2007","journal-title":"Oncogene"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/s41467-021-27322-4","article-title":"Single-cell analysis of human primary prostate cancer reveals the heterogeneity of tumor-associated epithelial cell states","volume":"13","author":"Song","year":"2022","journal-title":"Nat. Commun."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1038\/nature09460","article-title":"The patterns and dynamics of genomic instability in metastatic pancreatic cancer","volume":"467","author":"Campbell","year":"2010","journal-title":"Nature"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1038\/nmeth.4463","article-title":"SCENIC: Single-cell regulatory network inference and clustering","volume":"14","author":"Aibar","year":"2017","journal-title":"Nat. Methods."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"e108647","DOI":"10.15252\/embj.2021108647","article-title":"Dynamic EMT: A multi-tool for tumor progression","volume":"40","author":"Brabletz","year":"2021","journal-title":"EMBO J."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"485189","DOI":"10.1155\/2011\/485189","article-title":"Prognostic factors for the development of biochemical recurrence after radical prostatectomy","volume":"2011","author":"Kotb","year":"2011","journal-title":"Prostate Cancer"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.eururo.2016.08.003","article-title":"EAU-ESTRO-SIOG Guidelines on Prostate Cancer. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent","volume":"71","author":"Mottet","year":"2017","journal-title":"Eur. Urol."},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Jang, A., Adler, D.M., Rauterkus, G.P., Bilen, M.A., and Barata, P.C. (2021). Immunotherapies in Genitourinary Oncology: Where Are We Now? Where Are We Going?. Cancers, 13.","DOI":"10.3390\/cancers13205065"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.eururo.2013.05.029","article-title":"The mutational landscape of prostate cancer","volume":"64","author":"Barbieri","year":"2013","journal-title":"Eur. Urol."},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Feng, D., Shi, X., Xiong, Q., Zhang, F., Li, D., and Yang, L. (2022). A gene prognostic index associated with epithelial-mesenchymal transition predicting biochemical recurrence and tumor chemoresistance for prostate cancer. Front. Oncol., 11.","DOI":"10.3389\/fonc.2021.805571"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"3630","DOI":"10.1158\/1078-0432.CCR-15-1434","article-title":"Epithelial-mesenchymal transition is associated with a distinct tumor microenvironment including elevation of inflammatory signals and multiple immune checkpoints in lung adenocarcinoma","volume":"22","author":"Lou","year":"2016","journal-title":"Clin. Cancer Res."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1182\/blood-2008-05-078154","article-title":"CD4 T cells: Fates, functions, and faults","volume":"112","author":"Zhu","year":"2008","journal-title":"Blood"},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Hato, L., Vizcay, A., Eguren, I., P\u00e9rez-Gracia, J.L., Rodr\u00edguez, J., G\u00e1llego P\u00e9rez-Larraya, J., Sarobe, P., Inog\u00e9s, S., D\u00edaz de Cerio, A.L., and Santisteban, M. (2024). Dendritic Cells in Cancer Immunology and Immunotherapy. Cancers, 16.","DOI":"10.3390\/cancers16050981"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1111\/imcb.70043","article-title":"Th17 cells in cancer: Plasticity-driven immunopathology and therapeutic opportunity","volume":"103","author":"Sutanto","year":"2025","journal-title":"Immunol. Cell Biol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.immuni.2018.03.004","article-title":"Cancer-Cell-Intrinsic Mechanisms Shaping the Tumor Immune Landscape","volume":"48","author":"Wellenstein","year":"2018","journal-title":"Immunity"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1016\/j.ymthe.2021.04.029","article-title":"The roles of PD-1\/PD-L1 in the prognosis and immunotherapy of prostate cancer","volume":"29","author":"Xu","year":"2021","journal-title":"Mol. Ther."},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Hosseinkhani, N., Derakhshani, A., Shadbad, M.A., Argentiero, A., Racanelli, V., Kazemi, T., Mokhtarzadeh, A., Brunetti, O., Silvestris, N., and Baradaran, B. (2021). The role of V-domain Ig suppressor of T cell activation (VISTA) in cancer therapy: Lessons learned and the road ahead. Front. Immunol., 12.","DOI":"10.3389\/fimmu.2021.676181"},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Singh, S., and Chakrabarti, R. (2019). Consequences of EMT-Driven Changes in the Immune Microenvironment of Breast Cancer and Therapeutic Response of Cancer Cells. J. Clin. Med., 8.","DOI":"10.3390\/jcm8050642"},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Yi, X., Zheng, X., Xu, H., Li, J., Zhang, T., Ge, P., Liao, D., Li, H., Lyu, X., and Ai, J. (2022). IGFBP7 and the Tumor Immune Landscape: A Novel Target for Immunotherapy in Bladder Cancer. Front. Immunol., 13.","DOI":"10.3389\/fimmu.2022.898493"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1007\/s00018-009-8632-6","article-title":"Fibulins: Multiple roles in matrix structures and tissue functions","volume":"66","author":"Iwamoto","year":"2009","journal-title":"Cell Mol. Life Sci."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"2345","DOI":"10.7150\/ijbs.70137","article-title":"MGP promotes CD8+ T cell exhaustion by activating the NF-\u03baB pathway leading to liver metastasis of colorectal cancer","volume":"18","author":"Rong","year":"2022","journal-title":"Int. J. Biol. Sci."},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"Meng, Y., Huang, K., Shi, M., Huo, Y., Han, L., Liu, B., and Li, Y. (2023). Research Advances in the Role of the Tropomyosin Family in Cancer. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms241713295"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1758835919864247","DOI":"10.1177\/1758835919864247","article-title":"TIMP-3 as a therapeutic target for cancer","volume":"11","author":"Su","year":"2019","journal-title":"Ther. Adv. Med. Oncol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1093\/nar\/30.1.207","article-title":"Gene Expression Omnibus: NCBI gene expression and hybridization array data repository","volume":"30","author":"Edgar","year":"2002","journal-title":"Nucleic Acids Res."},{"key":"ref_49","doi-asserted-by":"crossref","unstructured":"Cancer Genome Atlas Research Network, Weinstein, J.N., Collisson, E.A., Mills, G.B., Shaw, K.R., Ozenberger, B.A., Ellrott, K., Shmulevich, I., Sander, C., and Stuart, J.M. (2013). The Cancer Genome Atlas Pan-Cancer analysis project. Nat. Genet., 45, 1113\u20131120.","DOI":"10.1038\/ng.2764"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1016\/j.cell.2019.05.031","article-title":"Comprehensive Integration of Single-Cell Data","volume":"177","author":"Stuart","year":"2019","journal-title":"Cell"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.cels.2015.12.004","article-title":"The Molecular Signatures Database (MSigDB) hallmark gene set collection","volume":"1","author":"Liberzon","year":"2015","journal-title":"Cell Syst."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18637\/jss.v033.i01","article-title":"Regularization Paths for Generalized Linear Models via Coordinate Descent","volume":"33","author":"Friedman","year":"2010","journal-title":"J. Stat. Softw."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1111\/j.0006-341X.2000.00337.x","article-title":"Time-dependent ROC curves for censored survival data and a diagnostic marker","volume":"56","author":"Heagerty","year":"2000","journal-title":"Biometrics"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1038\/sj.bjc.6601119","article-title":"Survival analysis part II: Multivariate data analysis--an introduction to concepts and methods","volume":"89","author":"Bradburn","year":"2003","journal-title":"Br. J. Cancer."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1200\/JCO.2007.12.9791","article-title":"How to build and interpret a nomogram for cancer prognosis","volume":"26","author":"Iasonos","year":"2008","journal-title":"J. Clin. Oncol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1101\/gr.239244.118","article-title":"Maftools: Efficient and comprehensive analysis of somatic variants in cancer","volume":"28","author":"Mayakonda","year":"2018","journal-title":"Genome Res."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1007\/s12026-014-8516-1","article-title":"ImmPort: Disseminating data to the public for the future of immunology","volume":"58","author":"Bhattacharya","year":"2014","journal-title":"Immunol. Res."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"D948","DOI":"10.1093\/nar\/gky868","article-title":"The Comparative Toxicogenomics Database: Update 2019","volume":"47","author":"Davis","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"ref_59","unstructured":"UniProt Consortium (2021). UniProt: The universal protein knowledgebase in 2021. Nucleic Acids Res., 49, D480\u2013D489."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/11\/5017\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T13:09:02Z","timestamp":1780405742000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/11\/5017"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,2]]},"references-count":59,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2026,6]]}},"alternative-id":["ijms27115017"],"URL":"https:\/\/doi.org\/10.3390\/ijms27115017","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,2]]}}}